Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

pembrolizumab 6Radiosurgery 6Nivolumab 6Magnetic Resonance Spectroscopy 6Ifosfamide 5Bevacizumab 5cabozantinib 4Sunitinib 4Sirolimus 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Carboplatin 4Specimen Handling 3Sorafenib 3Paclitaxel 3Melphalan 3Ipilimumab 3Cyclophosphamide 3Busulfan 3temsirolimus 2lenvatinib 2etoposide phosphate 2cediranib 2belzutifan 2alectinib 2Trastuzumab 2Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Ursodeoxycholic Acid × CNS × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡